v3.25.4
Kenvue separation and discontinued operations (Tables)
 12 Months Ended
Dec. 28, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Disposal Groups, Including Discontinued Operations
Details of Net Earnings from Discontinued Operations, net of taxes are as follows:
(Dollars in Millions)
2023(1)
Sales to customers$10,036
Cost of products sold4,369
Gross profit5,667
Selling, marketing and administrative expenses3,085
Research and development expense258
Interest Income(117)
Interest expense, net of portion capitalized199
Other (income) expense, net1,092
(Gain) on separation of Kenvue(20,984)
Earnings from Discontinued Operations Before Provision for Taxes on Income22,134
Provision for taxes on income307
Net earnings from Discontinued Operations$21,827
(1)The Company ceased consolidating the results of the Consumer Health business on August 23, 2023, the date of the exchange offer, but continued to reflect any separation costs incurred as part of discontinued operations through the end of the fiscal fourth quarter.
The following table presents depreciation, amortization and capital expenditures of the discontinued operations related to Kenvue:
(Dollars in Millions)
 2023(1)
Depreciation and Amortization$383
Capital expenditures$162